The Steno National Collaborative Grant aims to:
- Strengthen clinical research between all Danish Steno Diabetes Centres.
- Ensure large-scale, long-term, patient-centred clinical research projects involving anational cohort of diabetes patients or people at risk of diabetes.
- Position Denmark at an international level in improving prevention and care for persons with diabetes or at risk of diabetes
Due to the collaborative purpose of the grant, the research project must bring researchersfrom all five Danish Steno Diabetes Centers together. This must be accomplished by establishing and/or using national cohorts with patients/persons at risk from all regions.
For Steno Diabetes Centers Copenhagen, Aarhus, Odense, Nordjylland, Steno Partner institutions are defined as hospitals with a cooperation agreement with the local Steno Diabetes Center. In Region Zealand, the PI/main applicant should be from one of the region’s hospitals.
The Principal Investor (PI)/main applicant
- The main (the PI) applicant must be anchored at a Danish Steno Diabetes Center.
- The main applicant must have documented experience with leading large-scale clinical research projects
- It is required that co-applicants from the four additional Danish Steno Diabetes Centers participate substantially in the project.
- In addition to the five Danish Steno Diabetes Centers, additional co-applicants from Steno Diabetes Center Greenland, Steno Diabetes Center Faroe Islands, a Steno Partner
institution or from a university, hospital, municipality or other non-profit research or diabetes care institutions in Denmark or abroad can also be part of the project.
A total of DKK 25 million is available for one grant for a five-year project.
he application process is a two-stage process. The project description for Stage 1 consists of a brief Expression of Interest of the proposed research project, addressing the aim and
hypotheses. A budget is not required for Stage 1. Up to three research projects will be invited to proceed to Stage 2, in which the main applicant will be asked to submit a comprehensive
application with a detailed project proposal of up to 30,000 characters. As part of the Stage 2 evaluation, the main applicant will be invited to present and discuss their proposed research project with the review committee. This committee meeting will be in August 2024. The application must be completed and submitted using NNF’s online application and grant
management system, NORMA, which can be accessed from: https://norma.novonordiskfonden.dk.
When all applications have been assessed, applicants will be notified about whether or not they have been awarded a grant. The notification e-mail will be sent from norma-norepl[email protected]. to the e-mail address entered on initial registration
Please note that the call deadline is moving in 2024. The deadline in 2024 is 23 January at 2 pm CET.